Take the Free Diagnostic

Treatment Foundations of the Renal System

CPR APPLICATIONS FOUNDATION · CHAPTER 7 · TREATMENT

Treatment Foundations of the Renal System

Organize the chapter before drilling into individual CPR concepts.

Supplemental foundation map: this page orients the detailed CPR Applications for Chapter 7. It is not part of the canonical CPR object inventory.

Browse the Foundations Library

Move through Chapter 7

Normal Foundations

Open normal foundations →

Abnormal Foundations

Open abnormal foundations →

Treatment Foundations · You are here

Open treatment foundations →

7.32 · SOURCE CPR FOUNDATION

Concept

Renal pharmacology is easiest when therapies are viewed as targeted changes to nephron transport, renal hemodynamics, and infection management. Drugs change solute delivery, arteriolar tone, aldosterone effect, or urinary antimicrobial exposure. The downstream electrolyte and acid-base effects usually follow from the site of action.

Pattern

Step 1 repeatedly asks three things: where the drug acts, what labs shift, and why creatinine changes after vascular tone is altered. New creatinine rise after RAAS blockade points to efferent arteriole logic. New potassium or pH change after diuretics points to distal sodium delivery or aldosterone effect.

Rule

  1. Localize the drug effect first: identify nephron segment, transporter, arteriolar target, or infection location.
  2. Track downstream solute delivery: changes in sodium delivery predict potassium and hydrogen secretion.
  3. For RAAS drugs, add hemodynamics: efferent dilation lowers intraglomerular pressure and can reduce GFR.

Applications

  • New RAAS blocker + creatinine rise → efferent-tone logic
  • Loop/thiazide kaliuresis → greater distal sodium delivery and aldosterone-dependent K⁺ secretion; potassium-sparing drugs tend to reduce K⁺ loss
  • Diuretic acid–base effects depend on transport site: loops/thiazides can promote alkalosis, while carbonic anhydrase inhibition or aldosterone blockade can promote acidosis
  • Transporter mechanism → adverse effect prediction
  • Tip: Downstream nephron effects often explain labs better than the headline mechanism.

CPR APPLICATIONS · ACTIVE REASONING

Predict treatment effects along the nephron

Choose a prediction before checking the mechanism. Expand the worked answers without scripts. No learner responses are stored or transmitted.

Decision 1: A patient takes a loop diuretic that inhibits NKCC2 in the thick ascending limb. What downstream effect commonly occurs?

Reveal worked answer and transfer

Best answer: More sodium delivery distally, with increased potassium loss. Loop diuretics impair Na-K-2Cl uptake and medullary hypertonicity; increased distal delivery often promotes kaliuresis and metabolic alkalosis.

Change one variable: How would a potassium-sparing diuretic alter the distal potassium effect?

Decision 2: A patient takes spironolactone. Which change is most likely, especially with concomitant kidney impairment?

Reveal worked answer and transfer

Best answer: Reduced potassium secretion and hyperkalemia risk. Mineralocorticoid receptor antagonism reduces aldosterone-responsive distal sodium uptake and potassium secretion; hyperkalemia is an important risk.

Change one variable: What combination with ACE inhibitors further increases hyperkalemia risk?

Decision 3: Following ACE inhibitor initiation, a patient develops a moderate rise in creatinine. Which physiologic change can contribute?

Reveal worked answer and transfer

Best answer: Reduced efferent tone and glomerular pressure. Efferent dilation can decrease intraglomerular hydrostatic pressure and filtration; degree, timing, volume status, and other findings determine significance.

Change one variable: What would a large creatinine rise prompt you to assess beyond the expected hemodynamic effect?

Change the mechanism

Compare the three scenarios without scripts
  • Loop diuretic (NKCC2): Greater distal sodium delivery, potassium wasting, and sometimes metabolic alkalosis.
  • Spironolactone (mineralocorticoid receptor): Reduced distal potassium secretion: monitor for hyperkalemia.
  • Acetazolamide (proximal carbonic anhydrase): More bicarbonate in urine and potential normal-anion-gap metabolic acidosis.

Explain it back: Choose one decision, trace the causal mechanism, and identify the observation that would overturn your prediction.

These unscored exercises do not establish psychometric validation or patient-specific treatment recommendations.

How to use this foundation map

  1. Identify the organizing mechanism.
  2. Recognize the pattern.
  3. Restate the rule without looking.
  4. Test transfer with the applications and question practice.

Pair CPR with the 5P Approach™ when solving cases and questions.

Back to Chapter 7 in the Foundations Library · USMLE Step 1 resources